ArticleBreast cancer research and treatment2025

Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis.

Chikako Iwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.